Novavax rallies on Swine flu breakthrough

[We will be discussing this article on tonight’s PID Radio show — don’t miss it! — PID]

Novavax stock rallied as much as 21 percent in Wednesday trading after the company said it has successfully created a swine flu vaccine.

The company made the vaccine at its new manufacturing facility in Rockville using technology that significantly reduces the time it takes to make a vaccine. Novavax says it created the vaccine candidate just 11 weeks after getting the gene sequence for the N1H1 strain from the U.S. Centers for Disease Control.

Full Report:  Novavax rallies on Swine flu breakthrough – Washington Business Journal: .

Be the first to comment

Leave a Reply

Your email address will not be published.